Ampio Pharma (AMPE) Reports Q3 Loss of $0.02/sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. WDAY
2. NVDA
3. META
4. JNJ
5. AAPL
6. AMAT
7. SPY
8. NRIX
9. ASML
10. S

Go back to Ampio Pharma (AMPE) Reports Q3 Loss of $0.02/sh

Ampio Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial Results and Provides Business Update

November 10, 2021 4:01 PM EST

ENGLEWOOD, Colo., Nov. 10, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for common inflammatory conditions, today reported results for the three- and nine-month periods ended September 30, 2021 and provided a corporate overview and business update.

... More